Table 3

Analyses of the included studies regarding PA, MMA and PAS

Author, yearPoint PAPre-PA
mean±SD
(cm3)
Post-PA
mean±SD
(cm3)
Max ADV
(mm)
Mand ADV
(mm)
Max:mand ADV ratioPre-PAS mean±SD
(mm)
Post-PAS
mean±SD
(mm)
Change in PAS
mean±SD
Fairburn et al 17 2007PASNANANA10NA11.12516.965.8±3
Jones et al 18 2010PASNANA12.05±2.716.23±5.72NA9.5±3.6613.28±5.722.55±3.18 (p>0.01)
Ronchi et al 19 2013PASNANA5.2±4.59.5±8.71.835±2.29.5±3.34.5±2.75 (p=0.74)
Bianchi et al 20 2014PAS12.9±4.0 (p<0.005)20.7±3.5 (p<0.005)10101.00NANANA
Schendel et al 21 2014PAS74.1176.99.49.51.016.07±2.39.60±4.13.53±3.2
Hsieh et al 22 2014PAS17.1±7.0 (p<0.001)23.2±8.6 (p<0.001)NANANANANANA
Veys et al 23 2017PAS28.78±8.4 (p=0.002)38.97±15.07 (p=0.002)8.0±2.19.8±1.81.23NANANA
de Ruiter et al 24 2017PASNANA7±2.2 (p=0.164)7±3.7 (p=0.248)1.007±3.714±4.47±4.05
  • *In the sample of Veys et al,23 only six patients were assessed out of 11 (pts 1, 2, 3, 5, 7 and 11).

  • †P values <0.005 were considered significant (95% CI).

  • ADV, advancement; mand, mandibular; max, maxillary; MMA, maxillomandibular advancement;NA, not assessed by the authors; PA, pharyngeal airway; PAS, pharyngeal airway space; pt, patient.